Mexico Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Mexico Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The Mexico Clinical Nutrition for Diabetes Care Market was valued at $32.25 Mn in 2023 and is predicted to grow at a CAGR of 5.03% from 2023 to 2030, to $45.47 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Sanofi, Pfizer Inc., and Abbott Nutrition among others.

ID: IN10MXPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: Mexico AUTHOR: Avantika Gupta

Buy Now

Mexico Clinical Nutrition for Diabetes Care Market Executive Summary

The Mexico Clinical Nutrition for Diabetes Care Market is at around $32.25 Mn in 2023 and is projected to reach $45.47 Mn in 2030, exhibiting a CAGR of 5.03% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Abbott Nutrition, Sanofi is known for its extensive portfolio of medications, including those essential for diabetes care. Nestlé Health Science, Pfizer Inc., and Roche Diabetes Care are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

Mexico Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Prevalence of Diabetes: In recent years, diabetes has been on the rise worldwide, primarily due to factors like inactive behaviors, poor dietary choices, and increasing levels of obesity. Mexico has a higher diabetes rate in comparison to numerous other nations. According to the International Diabetes Federation, roughly 16.9% of Mexican adults are living with diabetes. Recognition of the importance of nutrition therapy in treating diabetes is growing, as is the understanding of how clinical nutrition services and products can enhance patient results.

Technological Advancements: Advancements in glucose monitoring devices and insulin delivery systems have improved the ability to manage diabetes effectively. Diabetes management apps are becoming increasingly popular in Mexico. These apps can connect with glucose meters and CGMs, allowing patients to track trends, log data, and receive personalized insights. These technological innovations are driving the adoption of clinical nutrition products and services in Mexico.

Initiatives for diabetes management: The National Strategy for the Prevention and Control of Overweight, Obesity, and Diabetes was launched in 2013, this national strategy aims to address the diabetes epidemic in Mexico on three pillars. The first is public health, for which the aim is to promote healthy lifestyles through extensive education campaigns, ongoing monitoring of non-communicable diseases, and implementation of preventive actions. The second pillar is the provision of health care in a timely fashion, to promote early identification of people with risk factors or previous diagnoses of diabetes or obesity. The third pillar is regulation and fiscal policy for health, which includes a tax on sugary drinks and basic foods with high caloric density.

Market Restraints

Patient Affordability: Clinical nutrition products like specialized diabetic formulas and medical foods can be expensive, particularly compared to generic options. This can limit access for low-income patients who may struggle to afford these essential dietary supplements.

Lack of Access to Registered Dietitians: The availability of registered dietitians, who play a crucial role in providing personalized nutrition assessments, counseling, and education for people with diabetes, is limited in certain regions of Mexico, especially in rural areas. This could hinder the growth of the clinical nutrition market for diabetes care.

Regulatory Challenges: The clinical nutrition market is subject to stringent regulations governing the development, manufacturing, and marketing of these specialized products. Navigating the regulatory landscape, obtaining necessary approvals, and ensuring compliance with evolving guidelines can be time-consuming and costly for manufacturers, potentially slowing down market growth.

Regulatory Landscape and Reimbursement Scenario

Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) is responsible for regulating food and dietary products, including those intended for clinical nutrition. They establish safety and quality standards for these products. Food Supplements do not require a license, however, they need to be notified to COFEPRIS known as “consultation of product classification”.
Mexico has specific labeling requirements for clinical nutrition products, including the declaration of nutritional information, ingredients, and any health claims. The labeling must comply with the Mexican Official Standard NOM-051-SCFI/SSA1-2010, which establishes the general specifications for the labeling of pre-packaged foods and non-alcoholic beverages. Secretaría de Salud (SSA) plays a crucial role in establishing guidelines and protocols for diabetes management within the national healthcare system. This includes recommendations for the use of clinical nutrition as part of a comprehensive diabetes care plan.

The Mexican healthcare system, Seguro Popular (Popular Insurance), has some coverage for diabetes care. It has been replaced by the INSABI (Instituto de Salud para el Bienestar) since January 2020. INSABI aims to provide free health services and medications, including nutritional support, to uninsured and underinsured individuals. IMSS (Instituto Mexicano del Seguro Social) provides healthcare services to employees in the formal sector and their dependents. It covers clinical nutrition services, including those for diabetes care, as part of its healthcare services.

Competitive Landscape

Key Players

Here are some of the major key players in the Mexico Clinical Nutrition for Diabetes Care Market:

Abbott Nutrition
Pfizer Inc.
Bayer AG
Nestlé Health Science
Roche Diabetes Care
GlaxoSmithKline
Sanofi
Johnson & Johnson
Ascensia Diabetes Care Holdings
Novo Nordisk

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Mexico Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.